Study of New Drug for BK Virus in Kidney Transplant
Part of Infections, Kidney & urinary clinical trials.
This study tests a new medicine (AIC468) to see if it can help clear BK virus from the blood of people who have recently had a kidney transplant. Participants will receive either the study drug or a placebo (a dummy pill) to compare outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 or older.
- You received a kidney transplant within the last 12 months.
- This is your first time testing positive for BK virus since your transplant.
- Your BK virus level is between 1,000 and 1,000,000 copies per milliliter of blood.
- If you have a uterus, you agree to use highly effective birth control during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is creating a registry to learn how the immune system responds to BK virus in people who have recently received a kidney transplant from a deceased donor. Researchers hope this information will help improve treatment for BK virus infections.
This study looks at the type and genetic makeup of BK virus in kidney transplant patients and their donors. It aims to find patients at higher risk for a kidney infection caused by the virus, which could help improve monitoring and treatment.
This study tests a new treatment using lab-made antibodies to treat BK virus infection. It may help by controlling the virus in adults who already test BK positive.
This trial is testing a new blood test called T-ID that monitors your immune system after a kidney transplant. It may help doctors detect early signs of rejection so they can adjust your treatment before problems start.
This study looks at how the immune system reacts to the BK virus in people who have had a kidney transplant. It may help doctors understand why some patients develop the virus in their blood and how to better manage it.
This Phase 3 trial tests IVIG (an antibody medicine given through a vein) to treat BK virus infection after kidney or pancreas-kidney transplant. It may help lower the BK virus in the blood and protect the transplanted kidney.
Hear when a new BK Virus Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.